Merit Medical Reports Record Revenues for Second Quarter of 2018; Merit Adjusts 2018 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Merit Medical Systems, Inc. (MMSI) PT Raised to $67 at Needham & Company
July 24, 2018 6:31 AM EDTNeedham & Company raised its price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $67.00 (from $54.00) while maintaining a Buy rating.
Analsyt Mike Matson commented, "MMSI's 2Q18 revenue and EPS beat consensus. Management raised its 2018 revenue and EPS guidance but lowered its 2018 gross margin... More
Merit Medical Systems (MMSI) Tops Q2 EPS by 3c; Raises Outlook
July 23, 2018 4:04 PM EDTMerit Medical Systems (NASDAQ: MMSI) reported Q2 EPS of $0.43, $0.03 better than the analyst estimate of $0.40. Revenue for the quarter came in at $224.8 million versus the consensus estimate of $214.63 million.
GUIDANCE:
Merit Medical Systems sees FY2018 EPS of $1.60-$1.70, versus... More
